Daiwa Securities Group Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 12,072 shares of ALNY stock, worth $3.11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,072

Previous 11,292 6.91%

Holding current value

$3.11 Million

Previous $2.74 Million 20.99%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$233.81 - $287.01 $182,371 - $223,867	780 Added 6.91%	12,072 $3.32 Million
Q2 2024 Aug 07, 2024	BUY	$143.31 - $247.0 $53,168 - $91,637	371 Added 3.4%	11,292 $2.74 Million
Q1 2024 May 02, 2024	BUY	$146.51 - $198.2 $16,995 - $22,991	116 Added 1.07%	10,921 $1.63 Million
Q4 2023 Jan 31, 2024	BUY	$151.41 - $196.57 $60,564 - $78,628	400 Added 3.84%	10,805 $2.07 Million
Q3 2023 Nov 01, 2023	SELL	$170.77 - $211.65 $19,467 - $24,128	-114 Reduced 1.08%	10,405 $1.84 Million
Q2 2023 Jul 31, 2023	BUY	$185.01 - $212.05 $13,135 - $15,055	71 Added 0.68%	10,519 $2 Million
Q1 2023 May 02, 2023	BUY	$182.66 - $235.53 $111,422 - $143,673	610 Added 6.2%	10,448 $2.09 Million
Q4 2022 Feb 06, 2023	SELL	$185.53 - $241.31 $265,307 - $345,073	-1,430 Reduced 12.69%	9,838 $2.34 Million
Q3 2022 Nov 02, 2022	BUY	$138.54 - $232.0 $277,495 - $464,696	2,003 Added 21.62%	11,268 $2.26 Million
Q2 2022 Aug 09, 2022	BUY	$120.42 - $169.29 $37,571 - $52,818	312 Added 3.48%	9,265 $1.35 Million
Q1 2022 Apr 29, 2022	BUY	$127.18 - $173.91 $67,914 - $92,867	534 Added 6.34%	8,953 $1.46 Million
Q4 2021 Feb 03, 2022	SELL	$159.56 - $209.29 $12,126 - $15,906	-76 Reduced 0.89%	8,419 $1.43 Million
Q3 2021 Nov 05, 2021	BUY	$169.75 - $207.73 $457,815 - $560,247	2,697 Added 46.52%	8,495 $1.6 Million
Q2 2021 Aug 06, 2021	SELL	$128.63 - $176.89 $259,189 - $356,433	-2,015 Reduced 25.79%	5,798 $983,000
Q1 2021 May 03, 2021	BUY	$126.83 - $175.69 $304,265 - $421,480	2,399 Added 44.31%	7,813 $1.1 Million
Q4 2020 Feb 04, 2021	SELL	$122.97 - $147.0 $53,614 - $64,092	-436 Reduced 7.45%	5,414 $704,000
Q3 2020 Nov 02, 2020	BUY	$121.19 - $165.49 $57,565 - $78,607	475 Added 8.84%	5,850 $852,000
Q4 2019 Jan 31, 2020	SELL	$74.51 - $124.23 $5,886 - $9,814	-79 Reduced 1.45%	5,375 $619,000
Q3 2019 Nov 04, 2019	BUY	$70.9 - $87.82 $116,843 - $144,727	1,648 Added 43.3%	5,454 $439,000
Q1 2019 Apr 26, 2019	BUY	$72.76 - $93.45 $2,037 - $2,616	28 Added 0.74%	3,806 $356,000
Q4 2018 Feb 05, 2019	BUY	$62.67 - $88.33 $21,934 - $30,915	350 Added 10.21%	3,778 $275,000
Q1 2018 May 02, 2018	BUY	$115.92 - $148.54 $84,389 - $108,137	728 Added 26.96%	3,428 $408,000
Q4 2017 Feb 06, 2018	BUY	$114.49 - $139.98 $309,123 - $377,946	2,700	2,700 $343,000

Others Institutions Holding ALNY

# of Institutions

639

Shares Held

108M

Call Options Held

1.15M

Put Options Held

1.07M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Alnylam Pharmaceuticals, Inc. Transaction History